Hepion Pharmaceuticals
HEPA
#10702
Rank
S$0.82 M
Marketcap
S$0.07070
Share price
-3.51%
Change (1 day)
-88.97%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2025 (TTM): -S$6.17 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$19.99 Million, an increase over its 2023 earnings that were of -S$63.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$6.17 Million-69.16%
2024 -S$19.99 Million-68.5%
2023 -S$63.47 Million9.74%
2022 -S$57.84 Million37.49%
2021 -S$42.07 Million61.27%
2020 -S$26.09 Million174.55%
2019 -S$9.51 Million-31.28%
2018 -S$13.83 Million
2016 -S$27.44 Million6.03%
2015 -S$25.88 Million265%
2014 -S$7.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 3,034.96%๐Ÿ‡บ๐Ÿ‡ธ USA